Novozymes A/S (OTCMKTS:NVZMY) Stock Passes Above Fifty Day Moving Average – Here’s What Happened
by Mitch Edgeman · The Markets DailyNovozymes A/S (OTCMKTS:NVZMY – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $62.45 and traded as high as $64.96. Novozymes A/S shares last traded at $63.95, with a volume of 18,074 shares changing hands.
Novozymes A/S Stock Performance
The firm has a 50 day moving average of $62.46 and a two-hundred day moving average of $64.76. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.61 and a quick ratio of 1.00. The stock has a market cap of $29.13 billion, a PE ratio of 36.81, a PEG ratio of 1.25 and a beta of 1.09.
About Novozymes A/S
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).